[1]中华医学会.病毒性肝炎防治方案[J].中华传染病学杂志, 2001, 19 (1) ∶56-62.
|
[2]拉米夫定临床应用专家组.2004年拉米夫定临床应用专家共识[J].中华传染病学杂志, 2004, 12 (7) ∶425-428.
|
[3]Lee M, Lee SK, Son M, et al.Expression of Th1 and Th2 type cyto-kines responding to HBsAg in chronic hepatitisB patients[J].KoreanMed Sci, 1999, 14 (2) ∶175-181.
|
[4]Penna A, Del PG, Cavalli A, et al.Predominant Thelper1 cytokineprofile of hepatitis B virus nucleocapsid pecific Tcells in acute self-limited hepatitis B[J].Hepatology, 1997, 25 (4) ∶1022-1027.
|
[5]姜荣龙, 卢桥生, 骆抗先, 等.慢性乙型肝炎病毒感染者外周血T辅助细胞1、2型因子的表达[J].中华传染病杂志, 2000, 18 (1) ∶26-28.
|
[6]俞富军, 何生松, 张淑玲。拉米夫定对慢性乙肝患者IL-2和IL-4影响的初步探讨[J].安徽医学, 2006, 27 (1) :27-29.
|
[7]何登明, 毛青.拉米夫定治疗对慢性乙型肝炎患者Th1/Th2平衡的影响及意义[J].中华肝脏病杂志, 2004, 12 (8) :495-496.
|
[8]彭文伟.传染病学[M].北京:人民卫生出版社, 2000∶43.
|
[9]Pol S, Michel ML, Brechot C, et al.Immune therapy of hepatitis Bvirus chronic infection[J].Hepatology, 2000, 31 (2) ∶548-549.
|
[10]陈紫荣.病毒性肝炎[M].北京:人民卫生出版社, 2001∶423.
|
[1] | Wang WeiZhao, Xiang XiaoXing. Immunological mechanism of Treg/Th17 and Th1/Th2 balance in autoimmune hepatitis and new targets for diagnosis and treatment[J]. Journal of Clinical Hepatology, 2019, 35(8): 1874-1877. doi: 10.3969/j.issn.1001-5256.2019.08.051 |
[2] | Huang HongFei, He DengMing, Wu QuanXin, Li MaoShi, Zhu Peng, Wang YuMing. Changes in serum levels of Th1 /Th2 cytokines in HBeAg- positive pregnant women with HBV infection after telbivudine treatment[J]. Journal of Clinical Hepatology, 2014, 30(6): 522-526. doi: 10.3969/j.issn.1001-5256.2014.06.011 |
[3] | Chen WeiHong, Chen Yan. Serum Th1 /Th2 cytokine levels and their clinical significance in patients with alcoholic liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(7): 631-635. doi: 10.3969/j.issn.1001-5256.2014.07.014 |
[4] | Xu LaMei, Sun DanLi, Zhang YuShu, Zhang ZhenYu, Yuan Jie, Du TongXin. The clinical significance of adiponectin expression and its diagnostic value combined with liver function tests and liver/spleen CT value in Non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2010, 26(2): 170-172. |
[5] | Luo FangQiong, Pan Yu, Liu JingJing, Zhang Peng, Niu JunQi, Jiang YanFang. The Impact of Adefovior dipivoxil on Th1/Th2 cytokines in chronic hepatitis B Patients[J]. Journal of Clinical Hepatology, 2010, 26(1): 19-21. |
[7] | Zhu Bin, Zhang Ping, Wang TianBao, Yu Meng. Measurement of Th1/Th2 cytokine levels in chronic hepatitis B during telbivudine therapy[J]. Journal of Clinical Hepatology, 2009, 25(6): 415-417. |
[10] | Zhan GuoQing, Jiang Shan, Zheng SanJu, Zhu Lin. Observations on dynamic changes of high level hepatitis B virus during sequential therapy of chronic hepatitis B with IFN α-1b and lamivudine.[J]. Journal of Clinical Hepatology, 2008, 24(1): 19-21. |
[11] | Li Jun, Chen XinYue, Zhao Hong, Yu YanYan, Si ChongWen, Han ZhongHou, Zhang WenJin, Chen YuPing, Chen Yong, Wang GuiQiang, Yu Min, Gong WeiBo, Xu JingHang, Wang Jun, Lin XiaoHong, Li XueYing. The relationship of hepatitis B virus genotypes and efficacy of lamivudine and interferon alpha 2b in the treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(3): 169-171. |
[13] | Li Jing, Liu SuFen, Ye LiHong, Du RuiQing, Lu JianHua, Lai JiaQi. Pathological characterization of the chronic hepatitis B with ALT less than 2×ULN/L[J]. Journal of Clinical Hepatology, 2008, 24(3): 189-190. |
[14] | Pei Bin, Chen ZhangRong, Huang WenQi, Xie JinZhen. The change of Th1/Th2 cytokines expression in treatment of chronic hepatitis C with IFN-α and ribavirin[J]. Journal of Clinical Hepatology, 2006, 22(3): 188-190. |
[15] | Huang LiHua, Wang JuanHua, Liu ZhiHui. Th1/Th2, Tc1/Tc2 expression in peripheral blood cell of the patients with chronic severe B viral hepatitis[J]. Journal of Clinical Hepatology, 2005, 21(2): 91-92. |
[20] | Wang ShaoYang, Lin YuMei, Ma WeiMin, Zhang ShuLin. The effect of HBV-specific antigen HBcAg and HBeAg on TH1/TH2 like cell response[J]. Journal of Clinical Hepatology, 2001, 17(1): 32-33. |